Literature DB >> 32548755

Prediction Efficacy for Clinical Outcome of Prognostic Nutritional Index in Patients with Resectable Biliary Tract Cancer Depends on Sex and Obstructive Jaundice Status.

Jie Wang1,2, Xiaobo Bo1,2, Min Li1,2, Lingxi Nan1,2, Changcheng Wang1,2, Zhihui Gao1,2, Tao Suo1,2, Xiaoling Ni1,2, Han Liu1,2, Jun Han1, Pinxiang Lu3, Houbao Liu4,5,6, Yueqi Wang7,8.   

Abstract

BACKGROUND: The Prognostic Nutritional Index (PNI), a marker of nutritional status and systemic inflammation, is a proven prognostic biomarker in some cancers. The predictive value of PNI in biliary tract cancer (BTC) has not been established.
OBJECTIVE: The aim of this study was to determine the relationship between the PNI and outcomes of resectable BTC.
METHODS: In total, 430 patients with stage I-III resectable BTC [gallbladder cancer (GBC), n = 212; cholangiocarcinoma (CHO), n = 218] who had attended Fudan University Zhongshan Hospital were enrolled. The relationship between the PNI and clinical outcomes was evaluated both in the whole cohort and in selected subgroups.
RESULTS: Eligible patients were classified into PNI-low (PNI < 45) and PNI-high (PNI ≥ 45) groups. The PNI-low group had significantly worse overall survival (OS) in both the whole cohort (p = 0.002) and in the GBC subgroup (p = 0.001), but had similar OS as the PNI-high group in the CHO subgroup (p = 0.328). Multivariate analysis revealed that low PNI is an independent risk factor for worse survival in GBC (hazard ratio 1.623, 95% confidence interval 1.063-2.480, p = 0.026). PNI was found to predict clinical outcome in women (p < 0.001) and patients without obstructive jaundice (p = 0.017) with GBC, but was not a prognostic factor in any subgroup with CHO. The estimated area under the time-dependent receiver operating characteristic curve was significantly greater when TNM stage was combined with PNI in women with GBC.
CONCLUSIONS: PNI is an independent predictor of OS in GBC, but not in CHO. It has no prognostic value in men with GBC or patients with obstructive jaundice.

Entities:  

Year:  2020        PMID: 32548755     DOI: 10.1245/s10434-020-08728-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy.

Authors:  Hanxin Feng; Feng Xu; Yang Zhao; Tianqiang Jin; Jianbo Liu; Rui Li; Tianyi Zhou; Chaoliu Dai
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738

2.  Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.

Authors:  Tao Wang; Jinfu Zhang; Wanxiang Wang; Xianwei Yang; Junjie Kong; Shu Shen; Wentao Wang
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

3.  Prediction Efficacy of Prognostic Nutritional Index and Albumin-Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 Patients.

Authors:  Qi Li; Chen Chen; Jian Zhang; Hong Wu; Yinghe Qiu; Tianqiang Song; Xianhai Mao; Yu He; Zhangjun Cheng; Wenlong Zhai; Jingdong Li; Dong Zhang; Zhimin Geng; Zhaohui Tang
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.